| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 191.67M | — |
| Operating expense | — | — |
| Net income | 75.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 41L.F returned +5.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -3.3% |
| 1 year | +5.2% |
| 5 years | +27.1% |
| 10 years | +412.8% |
| All-time high | €88.50 (Jun 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 41L.F would be worth today ›Yes. Laboratorios Farmaceuticos Rovi, S.A. paid 1 dividend over the past 12 months. The most recent was €0.96 per share on Jul 13, 2026. The dividend yield is 1.62%.
Laboratorios Farmaceuticos Rovi, S.A. is part of the Healthcare sector.
Laboratorios Farmaceuticos Rovi, S.A. has a market cap of 3.07B EUR, based on the latest quote.
